This is a discussion on Fitch projects 23 new drug filings for 2010 within the Biotechnology News forum, part of the Industry News and Updates category; Looking at the new drug approval pace so far, Fitch Ratings estimates that drug authorities will field 23 new drug ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Looking at the new drug approval pace so far, Fitch Ratings estimates that drug authorities will field 23 new drug filings by the end of the year--the same slow pace seen over the past few years. The FDA has OK'd six new molecular entities and one vaccine while the European Medicines Agency authorized the marketing of five NMEs and two vaccines. Fitch also expects that licensing will be favored over consolidation deals in 2010. Release
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Everything you need to know about Specialty pipeline from 4/2010 through 9/2010 | chantell.reagan | Specialty Drug Pipeline by Month | 0 | 04-02-2010 12:28 PM |
| Everything you need to know about Non-specialty pipeline from 4/2010 through 9/2010 | chantell.reagan | Non-Specialty Drug Pipeline by Month | 0 | 04-02-2010 12:18 PM |
| Scientists lament HIPAA's impact on new research projects | industry_news | Biotechnology News | 0 | 06-17-2008 07:00 PM |